Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures

v3.4.0.3
Segment Disclosures
 3 Months Ended
Mar. 31, 2016
Segment Reporting [Abstract]  
Segment Disclosures
14. Segment Disclosures
 
The Company has two reportable segments, Engineering Services and Medical Devices. Engineering Services generates revenue principally from collaborative research and development service arrangements, technology license agreements, and government grants where the Company uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities such as such as the National Science Foundation and the Defense Advanced Research Projects Agency. The Medical Devices segment designs, engineers, and manufactures exoskeletons for applications in the medical and military markets.
 
The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets, and one segment provides a service and the other manufactures and distributes a unique product. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.
 
Segment reporting information is as follows:
 
 
 
Medical
 
Engineering
 
 
 
 
 
Devices
 
Services
 
Total
 
Three months ended March 31, 2016
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
8,057
 
$
429
 
$
8,486
 
Cost of revenue
 
 
6,669
 
 
319
 
 
6,988
 
Gross profit
 
$
1,388
 
$
110
 
$
1,498
 
 
 
 
 
 
 
 
 
 
 
 
Three months ended March 31, 2015
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
985
 
$
704
 
$
1,689
 
Cost of revenue
 
 
798
 
 
488
 
 
1,286
 
Gross profit
 
$
187
 
$
216
 
$
403
 
 
Geographic information for revenue based on location of customer is as follows:
 
 
 
Three Months Ended March 31,
 
 
 
2016
 
2015
 
North America
 
$
4,521
 
$
1,271
 
All Other
 
 
3,965
 
 
418
 
 
 
$
8,486
 
$
1,689